文献速递神经肿瘤神经重症

基线衰弱状态与年龄对颅内脑膜瘤切除术后并发症和死亡的影响

Association of baseline frailty status and age with postoperative morbidity and mortality following intracranial meningioma resection.
PubMed 文献 · J Neurooncol · 2021-09-08

基于美国全国住院患者样本2015—2018年成人良性颅内脑膜瘤切除术的加权出院数据,采用多因素logistic回归和ROC曲线分析,评估11项改良衰弱指数(mFI)量化的衰弱与年龄对临床结局的关联及判别能力。结果显示衰弱与年龄均独立关联危及生命的并发症或死亡,而仅衰弱与住院时间延长相关,且衰弱对两终点的判别能力优于年龄。

要点

  • 衰弱较单纯高龄更能预测颅内脑膜瘤切除术后的不良事件与结局。
  • 随衰弱程度增加,Clavien-Dindo IV级并发症和住院时间延长的发生率均升高。
  • 术前可采用11项改良衰弱指数(mFI)辅助风险分层。

核心结论

  • 衰弱可能比单纯高龄更准确地预测颅内脑膜瘤切除术后的不良事件与结局。

研究设计与样本

  • 基于美国全国住院患者样本(National Inpatient Sample)2015—2018年成人良性颅内脑膜瘤切除术的加权出院数据,共识别20,250例患者(平均年龄60.6岁),采用复杂抽样多因素logistic回归与ROC曲线分析。

主要发现

  • 按mFI分层:稳健(mFI=0)35.4%(n=7170)、前衰弱(mFI=1)34.5%(n=6985)、衰弱(mFI=2)20.1%(n=4075)、重度衰弱(mFI≥3)10.0%(n=2020)。
  • 单因素分析中随衰弱加重,Clavien-Dindo IV级(危及生命,含导致死亡)并发症发生率为1.3% vs. 3.1% vs. 6.5% vs. 9.4%(p<0.001),住院时间延长(eLOS)为15.4% vs. 22.5% vs. 29.3% vs. 37.4%(p<0.001)。
  • 多因素分析中衰弱加重(aOR 1.40,95%CI 1.17—1.68,p<0.001)与年龄(aOR 1.20,95%CI 1.05—1.38,p=0.009)均独立关联危及生命并发症或死亡;衰弱加重(aOR 1.20,95%CI 1.10—1.32,p<0.001)关联eLOS,而年龄不关联。
  • mFI-11对两终点的判别能力优于年龄(AUC分别为0.69和0.61)。

临床怎么用

  • 术前除年龄外应评估衰弱状态(mFI),用于颅内脑膜瘤切除术的风险分层与预后沟通。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Although numerous studies have established advanced patient age as a risk factor for poor outcomes following intracranial meningioma resection, large-scale evaluation of frailty for preoperative risk assessment has yet to be examined. METHODS: Weighted discharge data from the National Inpatient Sample were queried for adult patients undergoing benign intracranial meningioma resection from 2015 to 2018. Complex samples multivariable logistic regression models and receiver operating characteristic curve analysis were performed to evaluate adjusted associations and discrimination of frailty, quantified using the 11-factor modified frailty index (mFI), for clinical endpoints. RESULTS: Among 20,250 patients identified (mean age 60.6 years), 35.4% (n = 7170) were robust (mFI = 0), 34.5% (n = 6985) pre-frail (mFI = 1), 20.1% (n = 4075) frail (mFI = 2), and 10.0% (n = 2020) severely frail (mFI ≥ 3). On univariable analysis, these sub-cohorts stratified by increasing frailty were significantly associated with the development of Clavien-Dindo grade IV (life-threatening) complications (inclusive of those resulting in mortality) (1.3% vs. 3.1% vs. 6.5% vs. 9.4%, p < 0.001) and extended length of stay (eLOS) (15.4% vs. 22.5% vs. 29.3% vs. 37.4%, p < 0.001). Following multivariable analysis, increasing frailty (aOR 1.40, 95% CI 1.17, 1.68, p < 0.001) and age (aOR 1.20, 95% CI 1.05, 1.38, p = 0.009) were both independently associated with development of life-threatening complications or mortality, whereas increasing frailty (aOR 1.20, 95% CI 1.10, 1.32, p < 0.001), but not age, was associated with eLOS. Frailty (by mFI-11) achieved superior discrimination in comparison to age for both endpoints (AUC 0.69 and 0.61, respectively). CONCLUSION: Frailty may be more accurate than advanced patient age alone for prognostication of adverse events and outcomes following intracranial meningioma resection.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Dicpinigaitis AJ, Kazim SF, Schmidt MH, et al. Association of baseline frailty status and age with postoperative morbidity and mortality following intracranial meningioma resection. J Neurooncol. 2021. PMID: 34495456. doi:10.1007/s11060-021-03841-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。